PORTLAND, Ore., April 15, 2008 (PRIME NEWSWIRE) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, announced today the launch of a program to find lead drug compounds for the treatment of obesity.
